Spironolactone Reduces Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

Study Questions:

What is the effect of spironolactone treatment on the incidence of cardiovascular and cerebrovascular (CCV) morbidity and mortality in hemodialysis (HD) patients?